Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 14-17 January 2019

January 18, 2019 – At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities, which cover all aspects of the risk management of the use of medicines: assessment of safety signals, risk management plans, periodic safety update reports and post-authorisation safety studies. The Committee did not start or conclude any referral procedures. More information on all safety reviews currently under evaluation is provided in … (leggi tutto)